The Global Orthopedic Software Market is set to increase and reach a higher CAGR during the predicted period 2017 to 2027 and reach $308.5 million by 2020. There is an expanding number of patients been afflicted by a number of orthopedic pathologies including osteoporosis, rheumatoid arthritis, cubital tunnel syndrome, Baker’s cysts, scoliosis osteoarthritis, and ligament injuries related to the knee and the hip. These pathologies affect and have an effect on the musculoskeletal system, which includes bones, muscles, nerves, ligaments, tendons, and cartilages. This ends in a decreased variety of motion, stiffness, swelling, and pain in the muscles, which eventually demands the need for surgical and orthopedic treatment. Besides the rising incidences of lifestyle disorders like obesity, it is another leading factor to orthopedic problems among patients; these are some of the factors propelling the growth of this market.

On the report called “Orthopedic Software Market (Product – Pre-operative Planning, Orthopedic PACS, Orthopedic EHR, Orthopedic Practice Management and Orthopedic Revenue Cycle Management; Mode of Delivery – On-premises, Web Based and Cloud Based; Applications – Orthopedic Surgery, Joint Replacement, Pediatric Assessment, and Fracture Management): Global Industry Analysis, Trends, Size, Share and Forecasts to 2027”,  the scientists define Global Orthopedic Software Market as the software that it was made to preserve the electronic health records of patients. The orthopedic software records the information before, during, and after orthopedic surgeries and further guides the doctors during the treatments and procedures. This software congregates patient data regarding medical parameters so they are advantageous to put together a pre-operative plan and achieve a better surgical procedure, with a reduced margin of complications. The study provides historical market data for 2015, 2016 revenue estimations are presented for 2017 and forecasts from 2018 till 2024.

Several regions such as North America, Europe, China, Japan, Southeast Asia, and India, center their attention on top manufacturers in global market, with capacity, production, price, revenue, and market share for each manufacturer, covering; this offers a stronger and effective business outlook by delivering multiple parameters of businesses. In general, this research study offers current as well as the futuristic business outlook according to the global trading concept with respect to the current Orthopedic Software market.


Leading Companies and top key players:

Brainlab AG.



GE Healthcare.

General Electric.

Greenway Health.

Healthfusion Inc.

IBM Watson Health.

Materialise N.V.

McKesson Corporation.

Medstrat Inc.

Merge Healthcare Inc.

QSI Management LLC.

Quality Systems Inc.


Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into:


Digital Templating / Pre-Operative Planning.

Orthopedic Her.

Practice Management.

Orthopedic Picture Archiving and Communication Systems.

Orthopedic Revenue Cycle Management.


Split by application, this report focuses on consumption, market share and growth rate of Orthopedic Software in each application, can be divided into:


Orthopedic Surgery.

Joint Replacement.

Fracture and Limb Deformity Management.

Pediatric Assessment.


Request a Sample Copy of this Report @:

Ask for Upto 40% Discount:


Report’s biggest Highlights:


  • The report provides a detailed analysis of current and future market trends to identify investment opportunities in the medical industry.
  • Key market trends through the business segments, regions and different countries.
  • Key developments and action plans observed in the market.
  • Market Dynamics such as Drivers, Restraints, Opportunities and other trends.
  • In-depth company profiles of key players and upcoming interested investors.
  • Market forecasts till 2027, using approximate market values as the base data.
  • Growth prospects among the emerging nations through 2027.
  • Market opportunities and recommendations for new investors.